Thyroid Cancer Much has been written and spoken about the potential risk for thyroid cancer in individuals taking GLP-1s
1,5 Healthy fats Monounsaturated and polyunsaturated fatty acids (MUFAs and PUFAs, respectively) enhance GLP-1 secretion through free fatty acid receptor and G-protein-coupled receptor signaling pathways, including GPR40, GPR119, and FFAR1/3
approval for retatrutide in obesity would likely be in late 2027 or 2028 , though an accelerated pathway is possible if the totality of evidence is sufficiently compelling
Every body is different, so results will vary based on your baseline levels and lifestyle factors
You understand and accept that the products are not to be used for any other purposes, including but not limited to medical, diagnostic, therapeutic, or recreational use